These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 34519836)
1. [Wound therapy with cold atmospheric plasma in severe recessive dystrophic epidermolysis bullosa : A pilot study]. Thiem A; Has C; Diem A; Klausegger A; Hamm H; Emmert S Hautarzt; 2022 May; 73(5):384-390. PubMed ID: 34519836 [TBL] [Abstract][Full Text] [Related]
2. A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa. Venugopal SS; Yan W; Frew JW; Cohn HI; Rhodes LM; Tran K; Melbourne W; Nelson JA; Sturm M; Fogarty J; Marinkovich MP; Igawa S; Ishida-Yamamoto A; Murrell DF J Am Acad Dermatol; 2013 Dec; 69(6):898-908.e7. PubMed ID: 24075228 [TBL] [Abstract][Full Text] [Related]
3. Electrochemotherapy, a local treatment for squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa. Bartolo J; Farricha V; Carvalhal S; Moura C; Abecasis N Dermatol Ther; 2020 Nov; 33(6):e14093. PubMed ID: 32720460 [TBL] [Abstract][Full Text] [Related]
4. Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases. Hwang A; Kwon A; Miller CH; Reimer-Taschenbrecker A; Paller AS Orphanet J Rare Dis; 2024 May; 19(1):206. PubMed ID: 38769503 [TBL] [Abstract][Full Text] [Related]
5. Patient-reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: A global cross-sectional survey. Eng VA; Solis DC; Gorell ES; Choi S; Nazaroff J; Li S; de Souza MP; Murrell DF; Marinkovich MP; Tang JY J Am Acad Dermatol; 2021 Nov; 85(5):1161-1167. PubMed ID: 32199895 [TBL] [Abstract][Full Text] [Related]